Scientific Advisory Board
Jerry Cacciatore R.Ph., MBA
Product Formulation, Generic Acquisition and cGMP Production Outsourcing
Robert Gow is Chairman of HSRx and a Member of the HSRx Board of Directors.Mr. Gow is the founder of HerbalScience Group and continues to serve as its Chairman. Prior to founding HerbalScience, Mr. Gow was a founding partner of Peak Capital, a VC fund that focused on investing in IT and Consumer Product start-ups. Successful investments included Prestige Brands which today is North America’s largest OTC Drug products company.
Mr. Gow enjoyed a successful Real Estate development and Consumer Loan career developing Powhatan Plantation, Greensprings Plantation Resort, Williamsburg National Golf Course, Greensprings Plantation, Greensprings Trust and Powhatan Associates Consumer Loan Portfolios.
Mr. Gow was a pioneer in promoting US business activities in Asia especially in the People’s Republic of China where he was instrumental in the forming of a number of business ventures with PRC government entities. Prior to his entry into Real Estate and Financial Services, Mr. Gow was the founder of several successful enterprises; an independent refined petroleum company, a major barging operation on the Mississippi River and a coal trading and transportation group.
Mr. Gow supports the licensing efforts and directs product development of HSRx.
Tommy Sullivan, Jr serves as the Managing Member of HSRx and is a Member of the HSRx Board of Directors.Mr. Sullivan is the Principal and Chairman of Title Security Agency LLC of Arizona. He is an owner/partner of CP Graphics, Lone Star Aggregators, Assimilate Solutions, Social Office Suite, Its on Me and Mr. Sullivan was a Founder of First Magnus Financial Corporation.
After moving to Arizona in 1972, Mr. Sullivan attended grammar school, high school and then the University of Arizona. Mr. Sullivan continues to work and reside in Tucson where he supports the community by being a current member and past Board member of the Tucson Conquistadores, Tucson Country Club and past Board member of Alliance Bank and the University of Arizona Foundation.
As Managing Member, Mr. Sullivan directs the day to day operations of HSRx.
Frank S Parise, Jr is the Chief Financial and Chief Administrative Officer of HSRx. Mr. Parise is a member of the Board of Directors of HSRx.Mr. Parise has been a private investor and hedge fund manager since 1998, specializing in Venture Capital investing, Foreign Currency trading and Equity Option trading. Mr. Parise was Co-Founder and Vice Chairman of the Board of Directors, Executive Vice President and Chief Administrative Officer of ASR Investments Corporation a publicly traded REIT with operations in Arizona, New Mexico, Texas and Washington State. Mr. Parise’s responsibilities included operational strategies, mergers and acquisitions, bond fundings, and public stock offerings.
Mr. Parise was a practicing CPA in the Phoenix office of Deloitte Haskins & Sells prior to beginning his successful career in developing and syndicating multiple Arizona real estate projects with the Allen Group and then the Estes Company.
Mr. Parise holds a Masters in Accounting Degree from the University of Illinois.
Mr. Parise manages all financial and administrative functions of HSRx.
James Edward Rothman was born on November 3, 1950 in Haverhill, Massachusetts (U.S.A.). He went to public schools in Haverhill, Massachusetts for elementary school through 8th grade, and then to Pomfret School (Pomfret, Connecticut) in 1964, from which he graduated in 1967. He then matriculated at Yale College, graduating summa cum laude in 1971 with a B.A. in Physics, having been Scholar of the House. Rothman then matriculated at the Harvard Medical School as an MD student, then joined the MD.-PhD program there. Ultimately, he graduated with a PhD in Biological Chemistry (thesis advisor, Eugene P. Kennedy) in 1976. He then joined the laboratory of Harvey F. Lodish in the Department of Biology at M.I.T. as a Damon Runyan postdoctoral fellow (1976–1978). In 1978 he joined the Department of Biochemistry at Stanford University as an assistant professor, and was promoted to associate professor with tenure (1981) and then full professor (1984). Rothman moved in 1988 to Princeton University in the Department of Molecular Biology where he held the E. R. Squib Chair of Molecular Biology. In 1991 he moved to the Memorial Sloan-Kettering Cancer Center where he founded and chaired the Cellular Biophysics and Biochemistry department, served as a Vice-Chairman of the Sloan-Kettering Institute for Cancer Research, and held the Paul Marks Chair. In 2004, Rothman joined the Columbia University College of Physicians and Surgeons as a professor in the Department of Physiology and Cellular Biophysics, where he also directed the Columbia Genome Center and held the Clyde and Helen Wu Chair of Chemical Biology. Then, in 2008 he returned to Yale and at the time of this writing is the Wallace Professor of Biomedical Sciences and Chair of the Department of Cell Biology and a Professor of Chemistry.Dr Rothman is a co-recipient of the 2013 Nobel Prize in Physiology or Medicine. Prior to the Nobel Prize, Rothman’s contributions to cell biology, biochemistry, and neuroscience were recognized by numerous prizes and honors. These include: the Eli Lilly Award for Fundamental Research in Biological Chemistry, U.S.A. (1986); the Passano Young Scientist Award, U.S.A. (1986); the Alexander Von Humboldt Award, Germany (1989); the Heinrich Wieland Prize, Germany (1990); election as Member, U.S. National Academy of Sciences (1993); the Rosenstiel Award in Biomedical Sciences, U.S.A. (1994); election as Fellow, American Academy of Arts and Sciences (1994); the Fritz Lipmann Award, U.S.A. (1995); elected as Member, Institute of Medicine, National Academy of Sciences, U.S.A. (1995); Honorary Degree, University of Regensburg, Germany (1995); elected as Foreign Associate, European Molecular Biology Organization (1995); the Gairdner Foundation International Award, Canada (1996); the King Faisal International Prize in Science, Saudi Arabia (1996); the Harden Medal of the British Biochemical Society, U.K. (1997); the Lounsbery Award, National Academy of Sciences, U.S.A. (1997); the Feodor Lynen Award, U.S.A. (1997); honorary MD and PhD degrees, University of Geneva (1997); the Jacobæus Prize, Denmark (1999); the Heineken Prize for Biochemistry, The Netherlands (2000); the Otto-Warburg Medal, German Biochemical Society, Germany (2001); the Louisa Gross Horwitz Prize, U.S.A. (2002); the Lasker Basic Research Award, U.S.A. (2002); elected as Honorary Member, Japanese Biochemical Society (2005); the Beering Award U.S.A. (2005); elected as Fellow, American Association for the Advancement of Science (2007); the E.B. Wilson Medal, American Society for Cell Biology (2010); the Kavli Prize in Neuroscience, Norway (2010); and the Massry Prize. U.S.A.
Dr Rothman serves as the Chairman of HSRx Biopharmaceutical’s Science Advisory Board. Dr Rothman is a co-developer of BRILLIANT™, the proprietary technology platform developed by HerbalScience Group that powers the HSRx food based compounds.
A member of the Scientific Advisory Board, Dr. Relkin is an internationally recognized expert on Alzheimer’s disease and related disorders. An American Board of Psychiatry and Neurology-certified neurologist, he graduated from Yale and earned MD and PhD degrees from New York’s Albert Einstein College of Medicine. Dr. Relkin is an Associate Professor of Neurology at the Weill Cornell Medical College and Founding Director of the Weill Cornell Memory Disorders Program. He has 20+ years of clinical trials experience, serving as principal investigator in over 20 therapeutic studies, including multi-center trials he designed. Over the past decade, Dr. Relkin pioneered the study of naturally occurring human antibodies for the treatment of Alzheimer’s. He led all three clinical trial phases of Intravenous Immunoglobulin as a potential Alzheimer’s treatment, including the pivotal National Institutes of Health (NIH) and Baxter co-sponsored study carried out at 45 sites (US and Canada). The author of numerous publications on neurodegenerative and traumatic disorders of the brain during the past 25 years, Dr. Relkin sits on editorial boards for three scientific journals. Additionally, he has been a reviewer for NIH and funding agencies in Europe and Australia, and has been a long-standing member of the Weill Cornell Institutional Review Board. In 2012, he was elected to the Board of Directors of The American Federation for Aging Research.
Dr. Malcolm A. Leissring is an award-winning biomedical researcher who is internationally recognized for his work on the molecular pathogenesis of diabetes and Alzheimer’s disease. He holds a bachelor’s degree from UC Berkeley, a Master’s degree from San Francisco State University, a Ph.D. from UC Irvine, and conducted his postdoctoral training at Harvard Medical School in the laboratory of Dennis J. Selkoe, M.D., who is widely considered as the world’s leading researcher in Alzheimer’s disease. Dr. Leissring has held faculty positions at Harvard Medical School, The Scripps Research Institute, and Mayo Clinic and currently works at UC Irvine’s Institute for Memory Impairments and Neurological Disorders (UCI MIND). Dr. Leissring’s research has been funded by grants from the National Institutes of Health and numerous private foundations, and he has published dozens of peer-reviewed articles appearing in top-tier scientific journals such as Nature, Neuron, and the Proceedings of the National Academy of Sciences. For his pioneering work on Alzheimer’s disease, Dr. Leissring has received awards from many prestigious organizations, including the Alzheimer’s Association, the Ellison Medical Foundation, the American Federation for Aging Research and the American Diabetes Association. He is an avid guitar player and surfer and currently resides in Laguna Beach.
Dan Li, PhD is HSRx’s Director of Extraction and Product Formulation. Dr. Li also serves as HerbalScience’s Director of Research & Development.
Dr. Li is a global leader in developing medicinal botanical extraction processes. Dr. Li led the development teams that developed the proprietary HerbalScience botanical extraction methods and processes. Starting in 2004 and continuing to present, Dr. Li has developed the extraction processes and methods for over 500 GRAS Status medicinal foods and botanicals.Dr. Li received her Ph.D. in Physical Chemistry from the Institute of Chemistry, Chinese Academy of Sciences (ICCAS) in Beijing, China. Dr. Li completed her Post-Doctoral work under Virginia Commonwealth University’s Dr. Mark McHugh, a global Super Critical CO2 extraction technology leader and innovator. Dr. Li returned to HSG after serving a 2 year appointment at the National Laboratory of Clean Energy, Institute of Chemical Physics, Chinese Academy of Sciences in Dalian, China.
Dr. Li manages all laboratory, food ingredient extraction and product formulation activities of HSRx.
Dr. Costin is an accomplished medical scientist known for his unique problem solving skills. After obtaining his Ph.D. in Microbiology and Immunology from Tulane, Joshua completed his Post-Doctoral work in Virology where he developed inhibitor compounds for dengue, chikungunya and Influenza viruses. Joshua has been a Medical Researcher, a Professor and a Crime Lab Scientist. His early studies of the human Genome and Proteome, and diverse experience provides the skills and leadership abilities to successfully lead the Biology efforts at HerbalScience and HSRx Biopharmaceutical.
Ryan Seltzer, Ph.D. joined the Company in 2015 as its Chief of Quantitative Analytics and Statistics. Ryan also serves as the Chief Scientific Officer for Translational Analytics and Statistics, a company focused on providing advanced analytics for technology based medical procedures. Ryan previously served as a Research Associate with Mayo Clinic and is also the founder/owner of Safety in Numbers, a statistical consulting firm. Ryan received a Ph.D. in Quantitative Psychology, Program Evaluation and Research Methodology from the University of Arizona, an MS degree in Quantitative Psychology from Illinois State University, an MA degree in Biological Anthropology from Kent State University, and a BA degree in Psychology from The Pennsylvania State University.
John M Williams was born in Virginia Beach, Virginia where he attended elementary school and Norfolk Academy. After graduating from Norfolk Academy in 2000 John chose to study Aerospace Engineering at Georgia Institute of Technology. John watched the American Aerospace Industry fall into fast decline while the demand for Biomedical Engineering skills was fast rising. At the request of Dr. Randal Alberte, an accomplished NSA Biochemistry section leader and University of Chicago professor, John interned for a year in the Biomedical & Biochemistry industries where he determined he could add value. In 2007 John entered the Engineering School at Florida Gulf Coast University where in 2009 he received his BS degree in Biomedical Engineering. John holds a State of Florida Engineering License.From 2009 to present John has led the operating team at HerbalScience’s DART-Accu-TOF MS department where he led the development of the methods, systems, software and databases that have provided the first real understanding of Botanical Medicinal Chemistry. John has under Confidentially Agreements developed the big data and bioinformatics software for the breakthrough HerbalScience Technology Platform, BRILLIANT™. John’s entrepreneurial skills helped him to develop a successful software development business and the related software packages that brought valuable new efficiencies to a century old industry.
John’s business interests are Analytical Software; Manufacturing Efficiencies & Safety, Process Design, Process Controls, Efficiencies and Automation. John’s personal interests are flying vintage airplanes, shotgun shooting, and market farming.
Jerry Cacciatore, R.Ph. MBA joined the Company in 2015 as a member of its Business Advisory Board advising the Company on matters involving pharmacy formulations, generic drug sourcing and cGMP manufacturing. Jerry also serves as a member and major stockholder of St. Mary’s NDS, a benefit management company, and was founder of various entities including St. Mary’s Managed Pharmacy Programs, a founder of First Script, Inc., a pharmacy benefit manager, Arizona Therapy Limb and Brace, St. Mary’s Medical Park Laboratory, St. Mary’s Medical Supply, and St. Mary’s Medical Park Pharmacy. Jerry was also a marketing representative for Eli Lilly and Company Pharmaceuticals. Jerry received a BS degree in Biology from Northern Illinois University, a BS degree in Pharmacy from the University of Arizona, and an MBA from the University of Phoenix.
Nathan C. Wright, Esq. joined the Company in 2014 as a member of its Business Advisory Board, and his law firm, Wright & Wright PLLC, has acted as outside General Counsel to the Company since its inception. Nathan was previously the Deputy General Counsel for one of the nation’s largest mortgage banking companies, and prior to that served as an associate in the law firm of Snell & Wilmer L.L.P. Nathan received a B.S. degree in Political Science from Texas Christian University and a J.D. from the University of Iowa College of Law.
Not long after Mark Kuipers got his MBA from Washington State University he began a career in brand and product marketing that quickly led him to the pinnacle of this profession. Mark’s unique marketing campaigns have created and delivered huge successes for scores of start-up and established brands all needing one thing, sales volume. Advanced Comfort, Ancestory.com, Bose, Bowflex, Nordic Track, Fisher Investments, Classmates.com, Select Comfort, Space Bag, Vital Wear, Sharper Image and over 40 other brands and products that have become nationally recognized brands and products are all beneficiaries of Mark’s genius. Mark leads our Direct to Consumer OTC Drug marketing efforts. When Mark is not developing a campaign for the next category leading OTC Drug product he enjoys spending time with his family, the great Montana outdoors and the Montana Arts Council.
Wolfgang H. Neumann graduated in 1986 from the Technical University in Munich, Germany with a Ph.D. in Science. After graduation, he worked for IBM and joined the team for computer network installations and IT consulting services worldwide. In addition, he was writing as a freelancer for PC Magazine for the categories of “computer networks” and the integration of “relational database management systems” in small and large corporations.
In 1989, he was hired as a professor by the “Chamber of Commerce” (European government organization) for creating Information Technology teaching concepts. In 1991, he was employed by Microsoft as a network and database engineer and was overlooking the development of database related software systems.
Wolfgang H. Neumann got transferred by Microsoft to the United States in 1995 and worked for an additional 2 years for that company where he participated in the development of software and database related applications. Today he provides IT consulting services for small and large corporations, overlooks network installations and focuses on security and cloud based solutions.